Mizuho analyst John Roberts raised the firm’s price target on Chemours (CC) to $19 from $16 and keeps an Outperform rating on the shares. The firm recommends the stock, saying per- and polyfluoroalkyl substance settlements “are trending in the right direction.” It cites higher market multiples for the target increase.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC: